Drug Delivery to the Eye

Advances in Organ Biology

Volumn 10, Issue , 2005, Pages 307-351

  Mitra, Ashim K ^a   Anand, Banmeet S ^a   Duvvuri, Sridhar ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645918597     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(05)10012-3     Document Type: Review

References (188)

1. Alm A., and Tornquist P. Lactate transport through the blood-retinal and the blood-brain barrier in rats. Ophthalmic. Res. 17 (1985) 181-184
2. Amidon G.L., Leesman G.D., and Elliott R.L. Improving intestinal absorption of water-insoluble compounds: A membrane metabolism strategy. J. Pharm. Sci. 69 (1980) 1363-1368
3. Anand B.S., and Mitra A.K. Mechanism of corneal permeation of L-valyl ester of acyclovir: Targeting the oligopeptide transporter on the rabbit cornea. Pharma. Res. 19 (2002) 1194-1202
4. Anand B.S., Patel J., and Mitra A.K. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: Competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2. J. Pharmacol. Exp. Ther. 304 (2003) 781-791
5. Antony A.C. The biological chemistry of folate receptors. Blood 79 (1992) 2807-2820
6. Asakura A. Histochemistry of hyaluronic acid of the bovine vitreous body by electronmicroscopy. Nippon Ganka Gakkai Zasshi 89 (1985) 179-191
7. Aukunuru J.V., Sunkara G., Bandi N., Thoreson W.B., and Kompella U.B. Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor. Pharm. Res. 18 (2001) 565-572
8. Bagshawe K.D. Antibody directed enzymes revive anti-cancer prodrugs concept. Br. J. Cancer 56 (1987) 531-532
9. Bagshawe K.D. The first Bagshawe lecture. Towards generating cytotoxic agents at cancer sites. Br. J. Cancer 60 (1989) 275-281
10. Bagshawe K.D. Antibody-directed enzyme prodrug therapy (ADEPT). Adv. Pharmacol. 24 (1993) 99-121
11. Bagshawe K.D., Springer C.J., Searle F., Antoniw P., Sharma S.K., Melton R.G., and Sherwood R.F. A cytotoxic agent can be generated selectively at cancer sites. Br. J. Cancer 58 (1988) 700-703
12. Bai J.P., and Amidon G.L. Structural specificity of mucosal-cell transport and metabolism of peptide drugs: Implication for oral peptide drug delivery. Pharm. Res. 9 (1992) 969-978
13. Balakrishnan A., Jain B., Yang C., Pal D., and Mitra A.K. Carrier mediated uptake of L-tyrosine and its competitive inhibition by model tyrosine linked compounds in a rabbit corneal cell line (SIRC)-strategy for the design of transporter/receptor targeted prodrugs. Int. J. Pharm. 247 1-2 (2002) 115-125
14. Balazs E.A., Laurent T.C., Laurent U.B.G., Deroche M.H., and Bunney D.M. Studies on the structure of the vitreous body. VII. Comparative biochemistry. Arch. Biochem. Biophys. 81 (1959) 464-479
15. Balimane P.V., Tamai I., Guo A., Nakanishi T., Kitada H., Leibach F.H., Tsuji A., and Sinko P.J. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem. Biophys. Res. Commun. 250 (1998) 246-251
16. Ban Y., and Rizzolo L.J. Regulation of glucose transporters during development of the retinal pigment epithelium. Brain Res. Dev. Brain Res. 121 (2000) 89-95
17. In: Bannerjee P.K., and Amidon G.L. (Eds). Design of Prodrugs Based on Enzymes-Substrate Specificity (1985), Elsevier, New York
18. Baudouin C., Chassain C., Caujolle C., and Gastaud P. Treatment of cytomegalovirus retinitis in AIDS patients using intravitreal injections of highly concentrated ganciclovir. Ophthalmologica 210 (1996) 329-335
19. Baum J., Peyman G.A., and Barza M. Intravitreal administration of antibiotic in the treatment of bacterial endophthalmitis. III. Consensus. Surv. Ophthalmol. 26 (1982) 204-206
20. Beauchamp L.M., Orr G.F., Miranda P.D., and Krenitsky T.A. Amino acid ester prodrugs of acyclovir. Antiviral Chem. Chemotherap. 3 (1992) 157-164
21. Ben-Nun J., Joyce D.A., Cooper R.L., Cringle S.J., and Constable I.J. Pharmacokinetics of intravitreal injection. Assessment of a gentamicin model by ocular dialysis. Invest. Ophthalmol. Vis. Sci. 30 (1989) 1055-1061
22. Berger U.V., and Hediger M.A. Distribution of peptide transporter PEPT2 mRNA in the rat nervous system. Anat. Embryol. (Berl.) 199 (1999) 439-449
23. Bergersen L., Johannsson E., Veruki M.L., Nagelhus E.A., Halestrap A., Sejersted O.M., and Ottersen O.P. Cellular and subcellular expression of monocarboxylate transporters in the pigment epithelium and retina of the rat. Neuroscience 90 (1999) 319-331
24. Bildin V.N., Iserovich P., Fischbarg J., and Reinach P.S. Differential expression of Na:K:2Cl cotransporter, glucose transporter 1, and aquaporin 1 in freshly isolated and cultured bovine corneal tissues. Exp. Biol. Med. (Maywood) 226 (2001) 919-926
25. Borst P., Evers R., Kool M., and Wijnholds J. A family of drug transporters: The multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92 (2000) 1295-1302
26. Boyum R., and Guidotti G. Effect of ATP binding cassette/multidrug resistance proteins on ATP efflux of Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 230 (1997) 22-26
27. Buchsbaum G., Sternklar M., Litt M., Grunwald J.E., and Riva C.E. Dynamics of an oscillating viscoelastic sphere: A model of the vitreous humor of the eye. Biorheology 21 (1984) 285-296
28. Burton P.S., Conradi R.A., and Hilgers R.A. Mechanism of peptide and protein absorption. 2. Transcellular mechanism of peptide and protein absorption: Passive aspects. Adv. Drug Deliv. Rev. 7 (1991) 365-386
29. Canning C.R., Greaney M.J., Dewynne J.N., and Fitt A.D. Fluid flow in the anterior chamber of a human eye. IMA J. Math. Appl. Med. Biol. 19 (2002) 31-60
30. Cantrill H.L., Henry K., Melroe N.H., Knobloch W.H., Ramsay R.C., and Balfour Jr. H.H. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results. Ophthalmology 96 (1989) 367-374
31. Chancy C.D., Kekuda R., Huang W., Prasad P.D., Kuhnel J.M., Sirotnak F.M., Roon P., Ganapathy V., and Smith S.B. Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor alpha in mammalian retinal pigment epithelium. J. Biol. Chem. 275 (2000) 20676-20684
32. Chen L., Wright L.R., Chen C.H., Oliver S.F., Wender P.A., and Mochly-Rosen D. Molecular transporters for peptides: Delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem. Biol. 8 (2001) 1123-1129
33. Chen L.X., Wang L.W., and Jacob T. The role of MDR1 gene in volume-activated chloride currents in pigmented ciliary epithelial cells. Sheng Li Xue Bao 54 (2002) 1-6
34. Christensen H.N. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol. Rev. 70 (1990) 43-77
35. Connor T.A., and Knox R.J. Prodrugs in cancer chemotherapy. Stem Cells 13 (1995) 501-511
36. Costabile B.S. Treatment of cytomegalovirus retinitis with intraocular implants. AORN J. 67 (1998) 356-360 362-355, 368; quiz 369-372.
37. Cundy K.C., Lynch G., Shaw J.P., Hitchcock M.J., and Lee W.A. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits. Curr. Eye Res. 15 (1996) 569-576
38. Cunha-Vaz J.G. The blood-retinal barriers. Doc. Ophthalmol. 41 (1976) 287-327
39. Daniel H., and Adibi S.A. Transport of beta-lactam antibiotics in kidney brush border membrane. Determinants of their affinity for the oligopeptide/H+ symporter. J. Clin. Invest. 92 (1993) 2215-2223
40. Dantzig A.H., and Bergin L. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta 1027 (1990) 211-217
41. Dey S., Patel J., Anand B.S., Jain-Vakkalagadda B., Kaliki P., Pal D., Ganapathy V., and Mitra A.K. Molecular evidence and functional expression of P-Glycoprotein (MDR1) in cornea and corneal epithelial cell line. Invest. Ophthalmol. Vis. Sci. 44 7 (2003) 2909-2918
42. Diamond J.G. Intraocular management of endophthalmitis. A systematic approach. Arch. Ophthalmol. 99 (1981) 96-99
43. Diaz-Llopis M., Martos M.J., Espana E., Cervera M., Vila A.O., Navea A., Molina F.J., and Romero F.J. Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients. Eperimental toxicity and pharmacokinetics, and clinical trial. Doc. Ophthalmol. 82 (1992) 297-305
44. Dieck S.T., Heuer H., Ehrchen J., Otto C., and Bauer K. The peptide transporter PepT2 is expressed in rat brain and mediates the accumulation of the fluorescent dipeptide derivative beta-Ala-Lys-Nepsilon-AMCA in astrocytes. Glia 25 (1999) 10-20
45. Doige C.A., and Ames G.F. ATP-dependent transport systems in bacteria and humans: Relevance to cystic fibrosis and multidrug resistance. Annu. Rev. Microbiol. 47 (1993) 291-319
46. Doring F., Martini C., Walter J., and Daniel H. Importance of a small N-terminal region in mammalian peptide transporters for substrate affinity and function. J. Membr. Biol. 186 (2002) 55-62
47. Einmahl S., Savoldelli M., D'Hermies F., Tabatabay C., Gurny R., and Behar-Cohen F. Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1533-1539
48. Fatt I. Flow and diffusion in the vitreous body of the eye. Bull. Math. Biol. 37 (1975) 85-90
49. Fei Y.J., Liu W., Prasad P.D., Kekuda R., Oblak T.G., Ganapathy V., and Leibach F.H. Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2. Biochemistry 36 (1997) 452-460
50. Field J.A., Zhang L., Brun K.A., Brooks D.P., and Edwards R.M. Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestine. Biochem. Biophys. Res. Commun. 258 (1999) 578-582
51. Fleisher D., Stewart B.H., and Amidon G.L. Design of prodrugs for improved gastrointestinal absorption by intestinal enzyme targeting. Methods Enzymol. 112 (1985) 360-381
52. Frank J.A., Dwyer A.J., Girton M., Knop R.H., Sank V.J., Gansow O.A., Magerstadt M., Brechbiel M., and Doppman J.L. Opening of blood-ocular barrier demonstrated by contrast-enhanced MR imaging. J. Comput. Assist. Tomogr. 10 (1986) 912-916
53. Fukasawa Y., Segawa H., Kim J.Y., Chairoungdua A., Kim D.K., Matsuo H., Cha S.H., Endou H., and Kanai Y. Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids. J. Biol. Chem. 275 (2000) 9690-9698
54. Ganapathy M.E., Brandsch M., Prasad P.D., Ganapathy V., and Leibach F.H. Differential recognition of beta-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J. Biol. Chem. 270 (1995) 25672-25677
55. Gelman R.A., and Blackwell J. Collagen-mucopolysaccharide interactions at acid pH. Biochim. Biophys. Acta 342 (1974) 254-261
56. Gerhart D.Z., Leino R.L., and Drewes L.R. Distribution of monocarboxylate transporters MCT1 and MCT2 in rat retina. Neuroscience 92 (1999) 367-375
57. Geroski D.H., and Edelhauser H.F. Transscleral drug delivery for posterior segment disease. Adv. Drug Deliv. Rev. 52 (2001) 37-48
58. Goffeau A., Park J., Paulsen I.T., Jonniaux J.L., Dinh T., Mordant P., and Saier Jr. M.H. Multidrug-resistant transport proteins in yeast: Complete inventory and phylogenetic characterization of yeast open reading frames with the major facilitator superfamily. Yeast 13 (1997) 43-54
59. Gottesman M.M., Pastan I., and Ambudkar S.V. P-glycoprotein and multidrug resistance. Curr. Opin. Genet. Dev. 6 (1996) 610-617
60. Greenwood J. Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro. J. Neuroimmunol. 39 (1992) 123-132
61. Groneberg D.A., Doring F., Theis S., Nickolaus M., Fischer A., and Daniel H. Peptide transport in the mammary gland: Expression and distribution of PEPT2 mRNA and protein. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E1172-E1179
62. Guo A., Hu P., Balimane P.V., Leibach F.H., and Sinko P.J. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line. J. Pharmacol. Exp. Ther. 289 (1999) 448-454
63. Halestrap A.P., and Price N.T. The proton-linked monocarboxylate transporter (MCT) family: Structure, function and regulation. Biochem. J. 343 Pt 2 (1999) 281-299
64. +-nucleoside cotransporter rCNT1. J. Biol. Chem. 276 (2001) 27981-27988
65. Han H., de Vrueh R.L., Rhie J.K., Covitz K.M., Smith P.L., Lee C.P., Oh D.M., Sadee W., and Amidon G.L. 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm. Res. 15 (1998) 1154-1159
66. Han H.K., and Amidon G.L. Targeted prodrug design to optimize drug delivery. AAPS PharmSci. 2 (2000) E6
67. Hargreaves K.M., and Pardridge W.M. Neutral amino acid transport at the human blood-brain barrier. J. Biol. Chem. 263 (1988) 19392-19397
68. Harris J.D., Gutierrez A.A., Hurst H.C., Sikora K., and Lemoine N.R. Gene therapy for cancer using tumour-specific prodrug activation. Gene Ther. 1 (1994) 170-175
69. Hashimoto N., Fujioka T., Toyoda T., Muranushi N., and Hirano K. Renin inhibitor: Transport mechanism in rat small intestinal brush-border membrane vesicles. Pharm. Res. 11 (1994) 1448-1451
70. Hatefi A., and Amsden B. Biodegradable injectable in situ forming drug delivery systems. J. Control Rel. 80 (2002) 9-28
71. +/glucose co-transporter. Nature 330 (1987) 379-381
72. Henderly D.E., Freeman W.R., Causey D.M., and Rao N.A. Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology 94 (1987) 425-434
73. Herrero-Vanrell R., and Refojo M.F. Biodegradable microspheres for vitreoretinal drug delivery. Adv. Drug Deliv. Rev. 52 (2001) 5-16
74. Himmelstein K.J., Guvenir I., and Patton T.F. Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye. J. Pharm. Sci. 67 (1978) 603-606
75. Holash J.A., and Stewart P.A. The relationship of astrocyte-like cells to the vessels that contribute to the blood-ocular barriers. Brain Res. 629 (1993) 218-224
76. Horibe Y., Hosoya K., Kim K.J., and Lee V.H. Carrier-mediated transport of monocarboxylate drugs in the pigmented rabbit conjunctiva. Invest. Ophthalmol. Vis. Sci. 39 (1998) 1436-1443
77. Hosoya K., Kondo T., Tomi M., Takanaga H., Ohtsuki S., and Terasaki T. MCT1-mediated transport of L-lactic acid at the inner blood-retinal barrier: A possible route for delivery of monocarboxylic acid drugs to the retina. Pharm. Res. 18 (2001) 1669-1676
78. Huber B.E., Richards C.A., and Austin E.A. Virus-directed enzyme/prodrug therapy (VDEPT). Selectively engineering drug sensitivity into tumors. Ann. N.Y. Acad. Sci. 716 (1994) 104-114 ; discussion 140-103
79. Hughes P.M., Krishnamoorthy R., and Mitra A.K. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: A novel ocular microdialysis technique. J. Ocul. Pharmacol. Ther. 12 (1996) 209-224
80. Hughes P.M., and Mitra A.K. Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2′-esters in rabbit epithelial keratitis. J. Ocul. Pharmacol. 9 (1993) 299-309
81. Inui K., Terada T., Masuda S., and Saito H. Physiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2. Nephrol. Dial. Transplant. 15 (2000) 11-13
82. Jabs D.A., Newman C., De Bustros S., and Polk B.F. Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology 94 (1987) 824-830
83. Kalsi G.S., Silver H.K., and Rootman J. Ocular pharmacokinetics of dacarbazine following subconjunctival versus intravenous administration in the rabbit. Can. J. Ophthalmol. 26 (1991) 247-251
84. Kanai Y., Segawa H., Chairoungdua A., Kim J.Y., Kim D.K., Matsuo H., Cha S.H., and Endou H. Amino acid transporters: Molecular structure and physiological roles. Nephrol. Dial. Transplant. 15 (2000) 9-10
85. Kang Y.S., Terasaki T., and Tsuji A. Acidic drug transport in vivo through the blood-brain barrier. A role of the transport carrier for monocarboxylic acids. J. Pharmacobiodyn. 13 (1990) 158-163
86. Kast C., Canfield V., Levenson R., and Gros P. Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence. J. Biol. Chem. 271 (1996) 9240-9248
87. Kawazu K., Yamada K., Nakamura M., and Ota A. Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1738-1744
88. Kilberg M.S., Stevens B.R., and Novak D.A. Recent advances in mammalian amino acid transport. Annu. Rev. Nutr. 13 (1993) 137-165
89. Kim Y.H., Kim D.U., Han K.H., Jung J.Y., Sands J.M., Knepper M.A., Madsen K.M., and Kim J. Expression of urea transporters in the developing rat kidney. Am. J. Physiol. Renal. Physiol. 282 (2002) F530-F540
90. Kiss A., Farah K., Kim J., Garriock R.J., Drysdale T.A., and Hammond J.R. Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochem. J. 352 Pt 2 (2000) 363-372
91. Kramer W., Dechent C., Girbig F., Gutjahr U., and Neubauer H. Intestinal uptake of dipeptides and beta-lactam antibiotics. I. The intestinal uptake system for dipeptides and beta-lactam antibiotics is not part of a brush border membrane peptidase. Biochim. Biophys. Acta 1030 (1990) 41-49
92. Kramer W., Durckheimer W., Girbig F., Gutjahr U., Leipe I., and Oekonomopulos R. Influence of amino acid side-chain modification on the uptake system for beta-lactam antibiotics and dipeptides from rabbit small intestine. Biochim. Biophys. Acta 1028 (1990) 174-182
93. Lalezari J.P., Friedberg D.N., Bissett J., Giordano M.F., Hardy W.D., Drew W.L., Hubbard L.D., Buhles W.C., Stempien M.J., Georgiou P., Jung D.T., and Robinson C.A. High dose oral ganciclovir treatment for cytomegalovirus retinitis. J. Clin. Virol. 24 (2002) 67-77
94. Lang J.C. Ocular drug delivery conventional ocular formulations. Adv. Drug Del. Rev. 16 (1995) 39-43
95. Le Bourlais C.A., Treupel-Acar L., Rhodes C.T., Sado P.A., and Leverge R. New ophthalmic drug delivery systems. Drug Develop. Industrial Pharmacy 21 (1995) 19-59
96. Lee B., Litt M., and Buchsbaum G. Rheology of the vitreous body. Part I: Viscoelasticity of human vitreous. Biorheology 29 (1992) 521-533
97. Lee B., Litt M., and Buchsbaum G. Rheology of the vitreous body: part 3. Concentration of electrolytes, collagen and hyaluronic acid. Biorheology 31 (1994) 339-351
98. Lee V.H. Membrane transporters. Eur. J. Pharm. Sci. 11 suppl. 2 (2000) S41-S50
99. In Precorneal corneal and postcorneal factors. In: Mitra A.K. (Ed). Ophthalmic Drug Delivery Systems (1993), Mercel Dekker, Inc., New York
100. Liscovitch M., and Lavie Y. Multidrug resistance: A role for cholesterol efflux pathways?. Trends Biochem. Sci. 25 (2000) 530-534
101. Loo T.W., and Clarke D.M. P-glycoprotein. Associations between domains and between domains and molecular chaperones. J. Biol. Chem. 270 (1995) 21839-21844
102. Lopez-Cortes L.F., Pastor-Ramos M.T., Ruiz-Valderas R., Cordero E., Uceda-Montanes A., Claro-Cala C.M., and Lucero-Munoz M.J. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1024-1028
103. Lopez-Cortes L.F., Ruiz-Valderas R., Lucero-Munoz M.J., Cordero E., Pastor-Ramos M.T., and Marquez J. Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits. Antimicrob. Agents Chemother. 44 (2000) 756-759
104. Macha S., and Mitra A.K. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique. Exp. Eye Res. 72 (2001) 289-299
105. Macha S., and Mitra A.K. Ocular pharmacokinetics of cephalosporins using microdialysis. J. Ocul. Pharmacol. Ther. 17 (2001) 485-498
106. Macha S., and Mitra A.K. Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis. Drug Metab. Dispos. 30 (2002) 670-675
107. Marmor M.F. Structure, Function and Disease of the Retinal Pigment Epithelium (1998), Oxford University Press, New York
108. Martin D.F., Sierra-Madero J., Walmsley S., Wolitz R.A., Macey K., Georgiou P., Robinson C.A., and Stempien M.J. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N. Engl. J. Med. 346 (2002) 1119-1126
109. Mathews M.B. The interaction of collagen and acid mucopolysaccharides. A model for connective tissue. Biochem. J. 96 (1965) 710-716
110. Maurice D. Review: Practical issues in intravitreal drug delivery. J. Ocul. Pharmacol. Ther. 17 (2001) 393-401
111. Meredith D., Temple C.S., Guha N., Sword C.J., Boyd C.A., Collier I.D., Morgan K.M., and Bailey P.D. Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1. Eur. J. Biochem. 267 (2000) 3723-3728
112. Merriman-Smith B.R., Young M.A., Jacobs M.D., Kistler J., and Donaldson P.J. Molecular identification of p-glycoprotein: A role in lens circulation?. Invest. Ophthalmol. Vis. Sci. 43 (2002) 3008-3015
113. Millay R.H., Klein M.L., Shults W.T., Dahlborg S.A., and Neuwelt E.A. Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am. J. Ophthalmol. 102 (1986) 626-632
114. Munck L.K., Grondahl M.L., Thorboll J.E., Skadhauge E., and Munck B.G. Transport of neutral, cationic and anionic amino acids by systems B, b(o,+), X(AG), and ASC in swine small intestine. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 126 (2000) 527-537
115. Narurkar M.M., and Mitra A.K. Prodrugs of 5-iodo-2′-deoxyuridine for enhanced ocular transport. Pharm. Res. 6 (1989) 887-891
116. Nashed Y.E., Anand B.S., and Mitra A.K. Synthesis and characterization of novel dipeptide ester prodrugs of acyclovir. Spectrochim. Acta A. Mol. Biomol. Spectrosc. 59 9 (2003) 2033-2039
117. Naumann H.N., and Memphis M.D. Postmortem chemistry of the vitreous in man. A M A Arch. Ophthol. 62 (1959) 356-363
118. +-dependent monocarboxylic acid transport pathway in rabbit renal brush border membranes. J. Membr. Biol. 72 (1983) 213-221
119. Okuda M., Saito H., Urakami Y., Takano M., and Inui K. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem. Biophys. Res. Commun. 224 (1996) 500-507
120. Pardridge W.M. Brain metabolism: A perspective from the blood-brain barrier. Physiol. Rev. 63 (1983) 1481-1535
121. Patel D.H., Crawford C.R., Naeve C.W., and Belt J.A. Cloning, genomic organization and chromosomal localization of the gene encoding the murine sodium-dependent, purine-selective, concentrative nucleoside transporter (CNT2). Gene 242 (2000) 51-58
122. Paulsen I.T., Brown M.H., and Skurray R.A. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60 (1996) 575-608
123. Pescovitz M.D., Rabkin J., Merion R.M., Paya C.V., Pirsch J., Freeman R.B., O'Grady J., Robinson C., To Z., Wren K., Banken L., Buhles W., and Brown F. Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob. Agents Chemother. 44 (2000) 2811-2815
124. Peyman G.A., Khoobehi B., Tawakol M., Schulman J.A., Mortada H.A., Alkan H., and Fiscella R. Intravitreal injection of liposome-encapsulated ganciclovir in a rabbit model. Retina 7 (1987) 227-229
125. Pow D.V. Amino acids and their transporters in the retina. Neurochem. Int. 38 (2001) 463-484
126. Putnam W.S., Pan L., Tsutsui K., Takahashi L., and Benet L.Z. Comparison of bidirectional cephalexin transport across MDCK and caco-2 cell monolayers: Interactions with peptide transporters. Pharm. Res. 19 (2002) 27-33
127. Reddy D.V.N., Rosenberg C., and Kinsey V.E. Steady state distribution of free amino acids with in aqueous humor, vitreous body, and plasma of the rabbit. Exp. Eye Res. 1 (1961) 175-181
128. Reddy J.A., and Low P.S. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J. Control Rel. 64 (2000) 27-37
129. +-nucleoside cotransporter (hCNT1). Am. J. Physiol. 272 (1997) C707-C714
130. Rizzolo L.J. Polarity and the development of the outer blood-retinal barrier. Histol. Histopathol. 12 (1997) 1057-1067
131. Ruetz S., and Gros P. Phosphatidylcholine translocase: A physiological role for the mdr2 gene. Cell 77 (1994) 1071-1081
132. Saha P., Yang J.J., and Lee V.H. Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells. Invest. Ophthalmol. Vis. Sci. 39 (1998) 1221-1226
133. Saier Jr. M.H. A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol. Mol. Biol. Rev. 64 (2000) 354-411
134. Sakurai E., Matsuda Y., Ozeki H., Kunou N., Nakajima K., and Ogura Y. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2043-2048
135. Sanitato J.J., Asbell P.A., Varnell E.D., Kissling G.E., and Kaufman H.E. Acyclovir in the treatment of herpetic stromal disease. Am. J. Ophthalmol. 98 (1984) 537-547
136. Sasaki H., Ichikawa M., Kawakami S., Yamamura K., Nishida K., and Nakamura J. In situ ocular absorption of tilisolol through ocular membranes in albino rabbits. J. Pharm. Sci. 85 (1996) 940-943
137. Schepens C.L. Clinical aspects of pathological changes in the vitreous body. Am. J. Ophthalmol. 38 (1954) 8-21
138. Schepens C.L., and Neetens A.N. The Vitreous and Vitreoretinal Interface (1987), Springer-Verlag, New York
139. Schlingemann R.O., Hofman P., Klooster J., Blaauwgeers H.G., Van der Gaag R., and Vrensen G.F. Ciliary muscle capillaries have blood-tissue barrier characteristics. Exp. Eye Res. 66 (1998) 747-754
140. Sebag J. The Vitreous: Structure, Function and Pathobiology (1989), Springer-Verlag, New York
141. Sekine T., Watanabe N., Hosoyamada M., Kanai Y., and Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J. Biol. Chem. 272 (1997) 18526-18529
142. Sharom F.J. The P-glycoprotein efflux pump: How does it transport drugs?. J. Membr. Biol. 160 (1997) 161-175
143. Shepherd P.R., and Kahn B.B. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 341 (1999) 248-257
144. Silverman M. Structure and function of hexose transporters. Annu. Rev. Biochem. 60 (1991) 757-794
145. Sinkula A.A., and Yalkowsky S.H. Rationale for design of biologically reversible drug derivatives: Prodrugs. J. Pharm. Sci. 64 (1975) 181-210
146. Sirotnak F.M., and Tolner B. Carrier-mediated membrane transport of folates in mammalian cells. Annu. Rev. Nutr. 19 (1999) 91-122
147. Smit J.J., Schinkel A.H., Oude Elferink R.P., Groen A.K., Wagenaar E., van Deemter L., Mol C.A., Ottenhoff R., van der Lugt N.M., van Roon M.A., et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75 (1993) 451-462
148. Smith A.J., Timmermans-Hereijgers J.L., Roelofsen B., Wirtz K.W., van Blitterswijk W.J., Smit J.J., Schinkel A.H., and Borst P. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett. 354 (1994) 263-266
149. Smith Q.R. Drug delivery to brain and the role of carrier-mediated transport. Adv. Exp. Med. Biol. 331 (1993) 83-93
150. In: Smith Q.R., and Stoll J. (Eds). Blood-Brain Barrier Amino Acid Transport (1988), Cambridge University Press, Cambridge
151. Smith S.B., Kekuda R., Gu X., Chancy C., Conway S.J., and Ganapathy V. Expression of folate receptor alpha in the mammalian retinol pigmented epithelium and retina. Invest. Ophthalmol. Vis. Sci. 40 (1999) 840-848
152. Smith T.J., and Ashton P. Sustained-release subconjunctival 5-fluorouracil. Ophthalmic. Surg. Lasers 27 (1996) 763-767
153. Stella V.J., Charman W.N., and Naringrekar V.H. Prodrugs. Do they have advantages in clinical practice?. Drugs 29 (1985) 455-473
154. Stella V.J., and Himmelstein K.J. Prodrugs and site-specific drug delivery. J. Med. Chem. 23 (1980) 1275-1282
155. Stone T.W., and Jaffe G.J. Reversible bull's-eye maculopathy associated with intravitreal fomivirsen therapy for cytomegalovirus retinitis. Am. J. Ophthalmol. 130 (2000) 242-243
156. Stuart F., Bradely S., and Cheng Y.L. Mathematical modelling of drug distribution in the vitreous humor. In: Mitra A.K. (Ed). Ophthalmic Drug Delivery Systems Second Edition, Revised and Expanded (Drugs and the Pharmaceutical Sciences) Vol. 130 (2003), Marcel Dekker, New York, NY March 2003.
157. Styrer L. Biochemistry (1981), W.H. Freeman Co, San Francisco
158. Sudimack J., and Lee R.J. Targeted drug delivery via the folate receptor. Adv. Drug. Deliv. Rev. 41 (2000) 147-162
159. Swann D.A. Chemistry and biology of the vitreous body. Int. Rev. Exp. Pathol. 22 (1980) 1-64
160. Takahashi H., Kaminski A.E., and Zieske J.D. Glucose transporter 1 expression is enhanced during corneal epithelial wound repair. Exp. Eye Res. 63 (1996) 649-659
161. Takahashi H., Ohara K., Ohmura T., Takahashi R., and Zieske J.D. Glucose transporter 1 expression in corneal wound repair under high serum glucose level. Jpn. J. Ophthalmol. 44 (2000) 470-474
162. Takanaga H., Maeda H., Yabuuchi H., Tamai I., Higashida H., and Tsuji A. Nicotinic acid transport mediated by pH-dependent anion antiporter and proton cotransporter in rabbit intestinal brush-border membrane. J. Pharm. Pharmacol. 48 (1996) 1073-1077
163. Takanaga H., Tamai I., and Tsuji A. pH-dependent and carrier-mediated transport of salicylic acid across Caco-2 cells. J. Pharm. Pharmacol. 46 (1994) 567-570
164. Tamai I., Sai Y., Ono A., Kido Y., Yabuuchi H., Takanaga H., Satoh E., Ogihara T., Amano O., Izeki S., and Tsuji A. Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1. J. Pharm. Pharmacol. 51 (1999) 1113-1121
165. Tamai I., Takanaga H., Maeda H., Ogihara T., Yoneda M., and Tsuji A. Proton-cotransport of pravastatin across intestinal brush-border membrane. Pharm. Res. 12 (1995) 1727-1732
166. Tamai I., and Tsuji A. Transporter-mediated permeation of drugs across the blood-brain barrier. J. Pharm. Sci. 89 (2000) 1371-1388
167. Terada T., Saito H., Mukai M., and Inui K.I. Identification of the histidine residues involved in substrate recognition by a rat H+/peptide cotransporter, PEPT1. FEBS Lett. 394 (1996) 196-200
168. Terada T., Sawada K., Irie M., Saito H., Hashimoto Y., and Inui K. Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2. Pflugers Arch. 440 (2000) 679-684
169. Terasaki T., Takakuwa S., Moritani S., and Tsuji A. Transport of monocarboxylic acids at the blood-brain barrier: Studies with monolayers of primary cultured bovine brain capillary endothelial cells. J. Pharmacol. Exp. Ther. 258 (1991) 932-937
170. Thorens B. Facilitated glucose transporters in epithelial cells. Annu. Rev. Physiol. 55 (1993) 591-608
171. Tiruppathi C., Balkovetz D.F., Ganapathy V., Miyamoto Y., and Leibach F.H. A proton gradient, not a sodium gradient, is the driving force for active transport of lactate in rabbit intestinal brush-border membrane vesicles. Biochem. J. 256 (1988) 219-223
172. +-dependent L-ascorbic acid transporters. Nature 399 (1999) 70-75
173. Unlu N., and Robinson J.R. Scleral permeability to hydrocortisone and mannitol in the albino rabbit eye. J. Ocul. Pharmacol. Ther. 14 (1998) 273-281
174. +- Independent Large Neutral Amino Acid Transporter LAT1 on Rabbit Cornea. Invest. Ophthalmol. Vis. Sci. Vol. 44 7 (2003) 2919-2927
175. Veloso Jr. A.A., Zhu Q., Herrero-Vanrell R., and Refojo M.F. Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. Invest. Ophthalmol. Vis. Sci. 38 (1997) 665-675
176. Waga J., Nilsson-Ehle I., Ljungberg B., Skarin A., Stahle L., and Ehinger B. Microdialysis for pharmacokinetic studies of ceftazidime in rabbit vitreous. J. Ocul. Pharmacol. Ther. 15 (1999) 455-463
177. (+)-dependent vitamin C transporter 1 (hSVCT1): Primary structure, functional characteristics and evidence for a non-functional splice variant. Biochim. Biophys. Acta 1461 (1999) 1-9
178. Williams E.F., Ezeonu I., and Dutt K. Nucleoside transport sites in a cultured human retinal cell line established by SV-40 T antigen gene. Curr. Eye Res. 13 (1994) 109-118
179. Wilson F.A. Intestinal transport of bile acids. Am. J. Physiol. 241 (1981) G83-G92
180. +/glucose cotransporter. Annu. Rev. Physiol. 55 (1993) 575-589
181. Wyatt H.J. Ocular pharmacokinetics and convectional flow: Evidence from spatio-temporal analysis of mydriasis. J. Ocul. Pharmacol. Ther. 12 (1996) 441-459
182. Yang C., and Mitra A.K. Nasal absorption of tyrosine-linked model compounds. J. Pharm. Sci. 90 (2001) 340-347
183. Yang C., Tirucherai G.S., and Mitra A.K. Prodrug based optimal drug delivery via membrane transporter/receptor. Expert Opin. Biol. Ther. 1 (2001) 159-175
184. Yang J.J., Kim K.J., and Lee V.H. Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers. Pharm. Res. 17 (2000) 533-538
185. Yasukawa T., Kimura H., Tabata Y., and Ogura Y. Biodegradable scleral plugs for vitreoretinal drug delivery. Adv. Drug Deliv. Rev. 52 (2001) 25-36
186. Yoon H., Fanelli A., Grollman E.F., and Philp N.J. Identification of a unique monocarboxylate transporter (MCT3) in retinal pigment epithelium. Biochem. Biophys. Res. Commun. 234 (1997) 90-94
187. Zhu T., Chen X.Z., Steel A., Hediger M.A., and Smith D.E. Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2. Pharm. Res. 17 (2000) 526-532
188. Zignani M., Einmahl S., Baeyens V., Varesio E., Veuthey J.L., Anderson J., Heller J., Tabatabay C., and Gurny R. A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: Subconjunctival tolerance and in vitro release. Eur. J. Pharm. Biopharm. 50 (2000) 251-255